IL6 and acute myeloid leukemia: Several cytokines, such as IL‐1β, IL‐6, or tumor necrosis factor alpha (TNFα), have been proven to contribute to proliferation, blast survival, resistance to treatment, and prognosis in acute myeloid leukemia (AML).1, 2, 3, 4